(Q34291421)

1 August 2017

1 reference

title

The pathological consequences of anaemia (English)

1 reference

1 August 2017

Silverberg DS

1

1 reference

1 August 2017

Iaina A

series ordinal

2

1 reference

1 August 2017

Wexler D

series ordinal

3

1 reference

1 August 2017

Blum M

series ordinal

4

1 reference

1 August 2017

publication date

1 February 2001

1 reference

International Journal of Laboratory Hematology

1 August 2017

published in

1 reference

1 August 2017

volume

23

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

1-6

1 reference

Congestive heart failure hospitalizations and survival in California: patterns according to race/ethnicity

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

A preliminary study of the effects of correction of anemia with recombinant human erythropoietin therapy on sleep, sleep disorders, and daytime sleepiness in hemodialysis patients (The SLEEPO study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Morbidity risk assessment in the surgically anemic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Effect of anaemia and cardiovascular disease on surgical mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Survival of patients with a new diagnosis of heart failure: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Precipitating factors leading to decompensation of heart failure. Traits among urban blacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Excess morbidity in patients starting uremia therapy without prior care by a nephrologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Evidence for amelioration of endothelial cell dysfunction by erythropoietin therapy in predialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Detection of functional iron deficiency during erythropoietin treatment: a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

A randomized controlled study of iron supplementation in patients treated with erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Effects of erythropoietin on muscle O2 transport during exercise in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Erythropoietin and systemic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Normalizing hematocrit in dialysis patients improves brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Iatrogenic congestive heart failure in older adults: clinical course and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Evaluation of oxygen availability with oxygen status algorithm in patients undergoing open heart surgery treated with epoetin beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Parathyroid hormone-mediated regulation of renal phosphate reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Effects of Epoetin alfa on hemostasis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

An overview of tumor necrosis factor alpha and the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00352.X

10.1046/J.1365-2257.2001.00352.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference